Nutrien Ltd vs UiPath Inc — how do they compare? Nutrien Ltd trades at $69.9 (market cap $33.52B), while UiPath Inc trades at $13.3 (market cap $6.81B). The key difference: Nutrien Ltd is far larger — about 4.9× UiPath Inc's market cap, and Nutrien Ltd pays a 3.14% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nutrien Ltd for 59 Days and UiPath Inc for 139 Days on average.
| NTR | PATH | |
|---|---|---|
Market Cap | $33.52B | $6.81B |
Volume | 1,154,412 | 22,766,109 |
Sector | Basic Materials | Technology |
52-Week High | $83.94 | $19.29 |
52-Week Low | $53.64 | $9.38 |
Typical Hold Time | 59 Days | 139 Days |
Enterprise Value | $45.32B | $5.61B |
Dividend Yield | 3.14% | — |
Signals from Pluang's Aura AI — not financial advice
Nutrien (NTR) trades at $69.87, down 1.87% on the day, with mixed technical signals showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 earnings of $2.61 per share, missing estimates, while revenue benefited from higher fertilizer prices. Analyst consensus remains moderately bullish with a $76.14 price target, though recent news highlights industry headwinds from potential Belarus potash imports.
The stock presents a value opportunity with reasonable P/E (14.16) and P/B (1.29) ratios, supported by strong cash flow generation. However, investors face risks from volatile fertilizer markets, competitive pressures, and cyclical agricultural demand. Near-term performance will depend on Q3 earnings results and management's strategic update at the November Investor Day.
UiPath (PATH) trades at $13.07, down 0.23% on the day, amid a bearish technical signal and mixed earnings history. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while net income is expected to turn positive. Recent news highlights AI partnerships and product innovations, but the stock faces headwinds from cautious analyst sentiment and technical resistance.
The outlook for PATH is cautiously optimistic, with strong revenue growth and a path to profitability offering upside potential, but risks include execution challenges and competitive pressures. The consensus price target of $15.13 suggests moderate upside from current levels, though investor sentiment remains divided.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →